Skip to main content
. 2023 Jan 1;41(3):692–700. doi: 10.5534/wjmh.220112

Table 3. Diffences of clinical parameters after treatment.

Variable Visit (wk) Maca (n=41) p-valuea Placebo (n=39) p-valuea p-valueb
Body weight (kg) 0 68.88±9.49 69.19±8.01
12 69.30±9.27 0.1009 70.01±8.00 0.0127 0.1871
Waist circumference (cm) 0 87.76±6.97 87.88±7.09
12 88.72±8.11 0.0269 88.57±6.88 0.0277 0.603
PSA (ng/mL) 0 1.31±0.92 1.55±1.15
12 1.35±1.14 0.1509 1.45±0.97 0.1580 0.0569
Serum testosterone (ng/mL) 0 4.40±1.64 5.46±1.88
12 4.41±1.76 0.9526 4.73±1.66 0.0156 0.444
Serum free testosterone (pg/mL) 0 7.54±1.84 8.74±1.98
12 7.59±2.06 0.5295 8.33±2.74 0.3051 0.9184
Serum total cholesterol (mg/dL) 0 161.66±32.42 179.97±35.42
12 159.44±37.31 0.3382 183.08±37.50 0.3441 0.1607
Serum HDL-C (mg/dL) 0 49.37±10.60 50.49±11.36
12 48.51±9.58 0.3676 49.33±12.25 0.3127 0.9429
Serum LDL-C (mg/dL) 0 88.63±28.78 103.51±31.54
12 89.44±33.26 0.6897 106.62±31.53 0.2595 0.3937
Serum triglyceride (mg/dL) 0 110.27±68.36 119.85±65.98
12 96.59±40.42 0.1412 135.44±82.70 0.0878 0.0047

Values are presented as mean±standard deviation.

Maca: Lepidium meyenii, PSA: prostate specific antigen, HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol.

aCompared within groups (paired t-test).

bCompared between groups (adjusted baseline).